659032

Thuốc Gốc

Small Molecule

659032 is the third genomics-derived small-molecule drug coming from a collaboration between Human Genome Sciences and GlaxoSmithKline to enter clinical development. 659032 is a second lipoprotein-associated phospholipase A2(Lp-PLA2) inhibitor.

Cơ Chế Tác Dụng : 659032 is the third genomics-derived small-molecule drug coming from a collaboration between Human Genome Sciences and GlaxoSmithKline to enter clinical development. 659032 is a second lipoprotein-associated phospholipase A2(Lp-PLA2) inhibitor. Lp-PLA2 is an enzyme associated with the formation of atherosclerotic plaques.

Chỉ Định : Cardiovascular Disorders and Atherosclerosis

Tài Liệu Tham Khảo Thêm

drugbank

http://www.drugbank.ca/drugs/DB05256

Bạn thấy hài lòng ?

Bạn chưa hài lòng ?

... loading